M-team and Mastitis and Milk Quality Research Unit, Department of Reproduction, Obstetrics, and Herd Health, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium.
J Dairy Res. 2013 Aug;80(3):309-18. doi: 10.1017/S0022029913000228. Epub 2013 Apr 10.
A randomised clinical trial was conducted to explore the effect of orally supplemented medium-chain fatty acids (MCFA) to heifers and cows starting 6-8 weeks prior to expected calving date on blood and milk polymorphonuclear neutrophilic leucocyte (PMNL) apoptosis between 1 and 3 d in milk (DIM). The effects of MCFA-supplementation on the likelihood of intramammary infections (IMI) in early lactation, and test-day somatic cell count (SCC) and average daily milk yield (MY) during the first 4 months of lactation were evaluated as well. Twenty-two animals were included of which half were orally supplemented with MCFA starting 6-8 weeks prior to calving and half served as non-supplemented controls. The PMNL viability in both blood and milk was quantified using dual-colour flow cytometry with fluorescein-labelled annexin and propidium iodide. In non-supplemented animals, % blood PMNL apoptosis significantly increased between start of supplementation and early lactation, reflecting a potential reduction in innate immune capacity, whereas this was not true in the MCFA-supplemented animals. Similar results were seen in milk PMNL apoptosis. Overall, the % apoptotic milk PMNL between 1 and 3 DIM was significantly lower in the MCFA-supplemented group compared with the non-supplemented group. There was no substantial effect of oral MCFA-supplementation on the likelihood of quarter IMI nor on the composite test-day milk SCC or average daily MY. In conclusion, oral MCFA-supplementation starting 6-8 weeks before expected calving date supported the blood and milk neutrophil viability in early lactating dairy cows. Still, this was not reflected in an improvement of udder health nor MY in early and later lactation. The results should trigger research to further unravel the mechanisms behind the observed immunomodulating effect, and the potential relevance for the cows' performances throughout lactation.
一项随机临床试验旨在探讨在预计分娩日期前 6-8 周开始向奶牛和后备牛口服补充中链脂肪酸(MCFA)对产后 1-3 天牛奶中血液和牛奶多形核中性粒细胞(PMN)凋亡的影响。还评估了 MCFA 补充对泌乳早期隐性乳腺炎(IMI)的可能性、产犊后第 1 天体细胞计数(SCC)和前 4 个月平均日产量(MY)的影响。共纳入 22 头动物,其中一半口服 MCFA 补充,另一半为未补充对照组。使用荧光素标记的 annexin 和碘化丙啶双染流式细胞术定量测定血液和牛奶中 PMN 的活力。在未补充组中,从开始补充到泌乳早期,PMN 凋亡的血液百分比显著增加,这反映了先天免疫能力的潜在降低,而在 MCFA 补充组中则不然。在牛奶 PMN 凋亡中也观察到了类似的结果。总的来说,在 MCFA 补充组中,产后 1-3 天牛奶中 PMN 的凋亡百分比明显低于未补充组。口服 MCFA 补充对 QIM 的可能性、复合产奶日 SCC 或平均日 MY 没有实质性影响。总之,在预计分娩日期前 6-8 周开始口服 MCFA 补充支持了泌乳早期奶牛血液和牛奶中性粒细胞的活力。然而,这并没有反映在乳房健康或早期和后期泌乳的产奶量上有所改善。这些结果应促使进一步研究,以阐明观察到的免疫调节作用背后的机制,以及其对奶牛整个泌乳期性能的潜在相关性。